Onkologie. 2008:2(2):110-116

MR Imaging in Differential Diagnostics of Liver Lesions

Viera Lehotská, Zuzana Berecová
II. rádiologická klinika LF UK a OÚSA, Bratislava

Diagnosis of focal liver lesions is „the daily bread“ of each radiologist and means a diagnostic problem. Although ultrasound (US) and computer-assisted tomography (CT) are routinely used in imaging algorithm, magnetic resonance imaging (MRI) is still the golden standard, especially in those cases, when former imaging cannot give an unambiguous determination of the biological characteristic of the lesion. MRI should be performed before any invasive procedure (biopsy).

Main advantages of MRI are better tissue resolution, multiplanar imaging feasibility (nowadays also possible with the newest CT equipment), absence of radiation, minimal risk of allergic reaction after contrast administration and especially the use of hepatotropic contrast media. On the other hand, the disadvantage of MRI is a limited examination in patients with metallic implants and absolute contraindication in patients with electronic implants.

Keywords: focal liver lesions, magnetic resonance imaging, differential diagnosis

Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lehotská V, Berecová Z. MR Imaging in Differential Diagnostics of Liver Lesions. Onkologie. 2008;2(2):110-116.
Download citation

References

  1. Buetow PC, Buck JL, Ros PR, Goodman ZD. Malignant Vascular Tumors of the Liver: Radiologic-Pathologic Correlation. In RadioGraphics,roč. 14, 1994, č. 1, s. 153-166. Go to original source...
  2. Elsayes KM, Narra VR, Mukundan G, Lammle M, Brown JJ. Focal Hepatic Lesions: Diagnostic Value of Enhancement Pattern Approach with Contrast enhanced 3D Gradient- Echo MR Imaging. In.: RadioGraphics, roč. 25, 2005, č. 5, s. 1299-1320. Go to original source... Go to PubMed...
  3. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR Contrast Agents for Liver Imaging: What, When, How. In.: Radio-Graphics, roč. 26, 2006, č. 6, s. 1621-1636. Go to original source...
  4. Grazioli L, Federle MP, Brancatelli, Ichikawa T, Olivetti L, Blachar A. Hepatic Adenomas: Imaging and Pathologic Findings. In.: Radiografi cs, roč. 21, 2001, č. 4, s. 877-894. Go to original source...
  5. Hussain SM, Zondervan PE, Ijzermans JNM, Schalm SW, de Man, Krestin RA. Benign versus Malignant Hepatic Nodules: MR Imaging Findings with Pathologic Correlation. In RadioGraphics, roč. 22, 2002, č. 5, s. 1023-1039. Go to original source... Go to PubMed...
  6. Koyam AT, Fletcher JG, Johnson CD, Kuo MS, Notohara K, Burgart LJ. Primary Hepatic Angiosarcoma: Findings at CT and MR Imaging. In Radiology, roč 22, 2002, s. 667-673. Go to original source... Go to PubMed...
  7. Lee JKT, Sagel SS, Stanley RJ, Heiken JP. Computed Body Tomography with MRI Correlation. 3. vyd. Philadelphia: Lippincott - Raven Publishers, 1998, ISBN 0-7817-0291-7.
  8. McLarney JK, Rucker PT, Bender GN, Goodman ZD, Kashitani N, Ros PR. Fibrolamellar carcinoma of the Liver: Radiologic-Pathologic Correlation. In: Radiographics, roč. 19, 1999, č. 2, s. 453-471. Go to original source... Go to PubMed...
  9. Mortele KJ, Ros PR. Cystic Focal Liver Lesions in the Adult: Differential CT and MR Imaging Features. In.: RadioGraphics, roč. 21, 2001, č. 4, s. 895-910. Go to original source... Go to PubMed...
  10. Powers C, Ros PR, Stoupis C, Johnson WK, Segel KH. Primary Liver Neoplasms: MR Imaging with Pathologic Correlation. In.: RadioGraphics, roč. 14, 1994, č. 3, s. 459-482. Go to original source... Go to PubMed...
  11. Semelka RC, Ascher SM, Reinhold C. MRI of the Abdomen and Pelvis. 1. vyd. New York: Wiley-Liss, Inc., 1997. 730 s. ISBN 0-471-16164-0.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.